Page last updated: 2024-11-06

floxuridine and Infant, Newborn, Diseases

floxuridine has been researched along with Infant, Newborn, Diseases in 1 studies

Floxuridine: An antineoplastic antimetabolite that is metabolized to fluorouracil when administered by rapid injection; when administered by slow, continuous, intra-arterial infusion, it is converted to floxuridine monophosphate. It has been used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.
floxuridine : A pyrimidine 2'-deoxyribonucleoside compound having 5-fluorouracil as the nucleobase; used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.

Infant, Newborn, Diseases: Diseases of newborn infants present at birth (congenital) or developing within the first month of birth. It does not include hereditary diseases not manifesting at birth or within the first 30 days of life nor does it include inborn errors of metabolism. Both HEREDITARY DISEASES and METABOLISM, INBORN ERRORS are available as general concepts.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Plotkin, SA1
Stetler, H1

Other Studies

1 other study available for floxuridine and Infant, Newborn, Diseases

ArticleYear
Treatment of congenital cytomegalic inclusion disease with antiviral agents.
    Antimicrobial agents and chemotherapy, 1969, Volume: 9

    Topics: Antiviral Agents; Child, Preschool; Cytarabine; Cytomegalovirus Infections; Female; Floxuridine; Hum

1969